Skip to main content

Table 6 Results from multivariate polytomous logistic regression analyses of factors associated with mild (<33% of hepatocytes affected ) and severe (>33% of hepatocytes affected) steatosis in 184 HIV-HCV coinfected patients treated with antiretroviral therapy

From: Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

  Mild steatosis AOR (95%CI) p Severe steatosis AOR (95%CI) p
HCV genotype 3 1.76 (0.72-4.30) 0.22 19.51 (4.49-84.73) <0.0001
HCV RNA (per 1 log10 increase) 1.80 (1.02-3.16) 0.04 14.86 (3.79-58.22) 0.0001
  1. Abbreviations: AOR, adjusted odds ratio; CI, confidence intervals.